Zoetis Inc. (LON:0M3Q)
128.01
+0.71 (0.56%)
At close: Jan 9, 2026
Zoetis Market Cap
Zoetis has a market cap or net worth of 41.81 billion as of January 9, 2026. Its market cap has decreased by -29.41% in one year.
Market Cap
41.81B
Enterprise Value
45.69B
Revenue
6.99B
Ranking
n/a
PE Ratio
21.20
Stock Price
128.01
Market Cap Chart
Since February 1, 2013, Zoetis's market cap has increased from 9.85B to 41.81B, an increase of 324.37%. That is a compound annual growth rate of 11.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 41.81B | 1.47% |
| Dec 31, 2025 | 41.20B | -29.84% |
| Dec 31, 2024 | 58.72B | -17.46% |
| Dec 29, 2023 | 71.14B | 25.49% |
| Dec 30, 2022 | 56.69B | -33.52% |
| Dec 31, 2021 | 85.27B | 48.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.86B |
| GSK plc | 75.67B |
| Haleon | 32.73B |
| Smith & Nephew | 10.69B |
| Convatec Group | 4.80B |
| Hikma Pharmaceuticals | 3.49B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.72B |